Comparison of PD-L1 Immunohistochemistry Assays and Response to PD-L1 Inhibitors

被引：0
|
作者：
Dacic, S. [1 ]
Ancevski, K. [2 ]
Aberrbock, S. [2 ]
Herbst, C. [1 ]
Villaruz, L. [2 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pathol, Pittsburgh, PA USA
[2] Univ Pittsburgh, Hillman Canc Ctr, Hematol Oncol, Pittsburgh, PA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
PD-L1 assay response;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.02-047
引用
收藏
页码：S2115 / S2115
页数：1
相关论文
共 50 条
  • [1] Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
    Diggs, Laurence P.
    Hsueh, Eddy C.
    [J]. BIOMARKER RESEARCH, 2017, 5
  • [2] Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
    Laurence P. Diggs
    Eddy C. Hsueh
    [J]. Biomarker Research, 5
  • [3] Comparison o PD-L1 immunohistochemical assays and the significance of PD-L1 expression in thymoma
    Yokoyama, Shintaro
    Miyoshi, Hiroaki
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (12) : 7553 - 7560
  • [4] A comparative study of PD-L1 diagnostic assays and the classification of patients as PD-L1 positive and PD-L1 negative
    Ratcliffe, Marianne J.
    Sharpe, Alan
    Midha, Anita
    Barker, Craig
    Scorer, Paul
    Walker, Jill
    [J]. CANCER RESEARCH, 2016, 76
  • [5] Standardization of PD-L1 immunohistochemistry
    Martinez-Morilla, Sandra
    Moutafi, Myrto
    Rimm, David L.
    [J]. MODERN PATHOLOGY, 2022, 35 (03) : 294 - 295
  • [6] PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
    Hirsch, Fred R.
    McElhinny, Abigail
    Stanforth, Dave
    Ranger-Moore, James
    Jansson, Malinka
    Kulangara, Karina
    Richardson, William
    Towne, Penny
    Hanks, Debra
    Vennapusa, Bharathi
    Mistry, Amita
    Kalamegham, Rasika
    Averbuch, Steve
    Novotny, James
    Rubin, Eric
    Emancipator, Kenneth
    McCaffery, Ian
    Williams, J. Andrew
    Walker, Jill
    Longshore, John
    Tsao, Ming Sound
    Kerr, Keith M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) : 208 - 222
  • [7] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    [J]. BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [8] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
  • [9] Multiplex immunohistochemistry/immunofluorescence is superior to tumor mutational burden and PD-L1 immunohistochemistry for predicting response to anti-PD-1/PD-L1 immunotherapy
    Hu, Weixian
    [J]. THORACIC CANCER, 2020, 11 (01) : 3 - 5
  • [10] Beyond inhibition against the PD-1/PD-L1 pathway: development of PD-L1 inhibitors targeting internalization and degradation of PD-L1
    Guo, Jiazheng
    Yu, Fengyi
    Zhang, Kuojun
    Jiang, Sheng
    Zhang, Xiangyu
    Wang, Tianyu
    [J]. RSC MEDICINAL CHEMISTRY, 2024, 15 (04): : 1096 - 1108
12345